Search by Drug Name or NDC
NDC 63323-0782-20 Vecuronium Bromide 1 mg/mL Details
Vecuronium Bromide 1 mg/mL
Vecuronium Bromide is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is VECURONIUM BROMIDE.
Product Information
| NDC | 63323-0782 |
|---|---|
| Product ID | 63323-782_ef0a4c9f-a65e-48dd-b625-eb76a18905f2 |
| Associated GPIs | 74200060102120 |
| GCN Sequence Number | 016619 |
| GCN Sequence Number Description | vecuronium bromide VIAL 20 MG INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 19671 |
| HICL Sequence Number | 003744 |
| HICL Sequence Number Description | VECURONIUM BROMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Vecuronium Bromide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Vecuronium Bromide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | VECURONIUM BROMIDE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205390 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0782-20 (63323078220)
| NDC Package Code | 63323-782-20 |
|---|---|
| Billing NDC | 63323078220 |
| Package | 10 VIAL in 1 CARTON (63323-782-20) / 20 mL in 1 VIAL (63323-782-23) |
| Marketing Start Date | 2016-06-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |